Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01217931
Title Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

kidney cancer

Therapies

Everolimus

Pazopanib

Bevacizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.